Piper Jaffray Companies reiterated their overweight rating on shares of Cooper Companies Inc (NYSE:COO) in a report released on Thursday. They currently have a $220.00 price target on the medical device company’s stock.
A number of other equities research analysts have also recently commented on the stock. Wells Fargo & Co raised shares of Cooper Companies from a market perform rating to an outperform rating in a research report on Monday, December 12th. Zacks Investment Research raised shares of Cooper Companies from a sell rating to a hold rating and set a $211.00 price target for the company in a report on Monday, February 6th. Jefferies Group LLC reaffirmed a buy rating and issued a $210.00 price target on shares of Cooper Companies in a report on Wednesday, December 7th. BMO Capital Markets reaffirmed a buy rating on shares of Cooper Companies in a report on Friday, March 3rd. Finally, Oppenheimer Holdings Inc. set a $203.00 price target on shares of Cooper Companies and gave the stock a hold rating in a report on Saturday, March 4th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and an average target price of $211.13.
Shares of Cooper Companies (NYSE:COO) traded down 0.69% on Thursday, hitting $199.11. The stock had a trading volume of 125,976 shares. Cooper Companies has a 1-year low of $152.09 and a 1-year high of $202.70. The firm has a 50 day moving average of $197.03 and a 200-day moving average of $183.75. The firm has a market capitalization of $9.74 billion, a price-to-earnings ratio of 32.81 and a beta of 0.56.
Cooper Companies (NYSE:COO) last posted its earnings results on Thursday, March 2nd. The medical device company reported $1.93 EPS for the quarter, beating the Zacks’ consensus estimate of $1.87 by $0.06. Cooper Companies had a net margin of 13.93% and a return on equity of 15.38%. The company earned $499.10 million during the quarter, compared to analysts’ expectations of $501.59 million. During the same quarter in the prior year, the company posted $1.83 earnings per share. Cooper Companies’s revenue for the quarter was up 11.0% compared to the same quarter last year. Equities analysts predict that Cooper Companies will post $9.25 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This news story was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2017/04/21/cooper-companies-inc-coo-receives-overweight-rating-from-piper-jaffray-companies-updated.html.
In other news, Director A Thomas Bender sold 1,500 shares of the firm’s stock in a transaction dated Friday, March 24th. The shares were sold at an average price of $200.94, for a total value of $301,410.00. Following the transaction, the director now directly owns 11,478 shares of the company’s stock, valued at $2,306,389.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jody S. Lindell sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $193.84, for a total transaction of $969,200.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,698 shares of company stock worth $4,461,175. Company insiders own 1.60% of the company’s stock.
Several institutional investors have recently bought and sold shares of COO. Hermes Investment Management Ltd. increased its position in Cooper Companies by 4.6% in the first quarter. Hermes Investment Management Ltd. now owns 441,562 shares of the medical device company’s stock valued at $88,264,000 after buying an additional 19,227 shares in the last quarter. State of Alaska Department of Revenue increased its position in shares of Cooper Companies by 266.9% in the first quarter. State of Alaska Department of Revenue now owns 6,146 shares of the medical device company’s stock worth $1,227,000 after buying an additional 4,471 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Cooper Companies by 1.1% in the first quarter. Nisa Investment Advisors LLC now owns 37,510 shares of the medical device company’s stock worth $7,498,000 after buying an additional 400 shares during the period. Fox Run Management L.L.C. purchased a new position in shares of Cooper Companies during the first quarter worth approximately $876,000. Finally, Private Trust Co. NA increased its position in shares of Cooper Companies by 75.0% in the first quarter. Private Trust Co. NA now owns 5,421 shares of the medical device company’s stock worth $1,083,000 after buying an additional 2,323 shares during the period. 97.44% of the stock is currently owned by hedge funds and other institutional investors.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.